Skip to main content

Advertisement

SpringerLink
Log in

Autoimmunity and inflammation: murine models and translational studies

  • Published:
Mammalian Genome Aims and scope Submit manuscript

Abstract

Autoimmune and inflammatory diseases, including type 1 diabetes, multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis, constitute an important and growing public health burden. However, in many cases our understanding of disease biology is limited and available therapies vary greatly in their efficacy and safety. Animal models of autoimmune and inflammatory diseases have provided valuable tools to researchers investigating their aetiology, pathology, and novel therapeutic strategies. Although such models vary in the degree to which they reflect human autoimmune and inflammatory diseases and caution is required in the extrapolation of animal data to the clinical setting, therapeutic approaches first evaluated in established animal models, including collagen-induced arthritis, experimental autoimmune encephalomyelitis, and the nonobese diabetic mouse, have successfully progressed to clinical investigation and practice. Similarly, these models have proven useful in providing support for basic hypotheses regarding the underlying causes and pathology of autoimmune and inflammatory diseases. Here we review selected murine models of autoimmunity and inflammation and efforts to translate findings from these models into both basic insights into disease biology and novel therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, Normier G, Chatenoud L, Thieblemont N, Bach JF (2006) Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 55:179–185

    PubMed  CAS  Google Scholar 

  • Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447–485

    PubMed  CAS  Google Scholar 

  • Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–341

    PubMed  CAS  Google Scholar 

  • Atochina O, Harn D (2006) Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp Dermatol 15:461–468

    PubMed  CAS  Google Scholar 

  • Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920

    PubMed  Google Scholar 

  • Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr (1993) Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177:57–68

    PubMed  CAS  Google Scholar 

  • Baxter AG (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7:904–912

    PubMed  CAS  Google Scholar 

  • Baxter AG, Healey D, Cooke A (1994) Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity. Scand J Immunol 39:602–606

    PubMed  CAS  Google Scholar 

  • Bevaart L, Vervoordeldonk MJ, Tak PP (2010) Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis? Arthritis Rheum 62:2192–2205

    PubMed  CAS  Google Scholar 

  • Bolt S, Routledge E, Lloyd I, Chatenoud L, Pope H, Gorman SD, Clark M, Waldmann H (1993) The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol 23:403–411

    PubMed  CAS  Google Scholar 

  • Brehm MA, Shultz LD, Greiner DL (2010) Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 17:120–125

    PubMed  Google Scholar 

  • Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244–247

    PubMed  CAS  Google Scholar 

  • Burek CL, Rose NR (2008) Autoimmune thyroiditis and ROS. Autoimmun Rev 7:530–537

    PubMed  CAS  Google Scholar 

  • Butler DM, Maini RN, Feldmann M, Brennan FM (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6:225–230

    PubMed  CAS  Google Scholar 

  • Chatenoud L (2010) Immune therapy for type 1 diabetes mellitus—What is unique about anti-CD3 antibodies? Nat Rev Endocrinol 6:149–157

    PubMed  CAS  Google Scholar 

  • Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91:123–127

    PubMed  CAS  Google Scholar 

  • Chatenoud L, Primo J, Bach JF (1997) CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 158:2947–2954

    PubMed  CAS  Google Scholar 

  • Chervonsky AV (2010) Influence of microbial environment on autoimmunity. Nat Immunol 11:28–35

    PubMed  CAS  Google Scholar 

  • Cooke A (2009) Review series on helminths, immune modulation and the hygiene hypothesis: How might infection modulate the onset of type 1 diabetes? Immunology 126:12–17

    PubMed  CAS  Google Scholar 

  • Cooke A, Tonks P, Jones FM, O’Shea H, Hutchings P, Fulford AJ, Dunne DW (1999) Infection with Schistosoma mansoni prevents insulin-dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 21:169–176

    PubMed  CAS  Google Scholar 

  • Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW (2004) Infection and autoimmunity: Are we winning the war, only to lose the peace? Trends Parasitol 20:316–321

    PubMed  Google Scholar 

  • Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61:97–108

    PubMed  CAS  Google Scholar 

  • Correale J, Farez MF (2011) The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 233:6–11

    PubMed  CAS  Google Scholar 

  • Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B (1980) Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283:666–668

    PubMed  CAS  Google Scholar 

  • DIAMOND Project Group (2006) Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866

    Google Scholar 

  • Ditzel HJ (2004) The K/BxN mouse: a model of human inflammatory arthritis. Trends Mol Med 10:40–45

    PubMed  CAS  Google Scholar 

  • Dunne DW, Cooke A (2005) A worm’s eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 5:420–426

    PubMed  CAS  Google Scholar 

  • Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681–1690

    PubMed  CAS  Google Scholar 

  • Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN (1994) Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125–1127

    PubMed  CAS  Google Scholar 

  • Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr, Weinstock JV (2003) Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 284:G385–G391

    PubMed  CAS  Google Scholar 

  • Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV (2004) Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 34:2690–2698

    PubMed  CAS  Google Scholar 

  • Esquivel PS, Rose NR, Kong YC (1977) Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med 145:1250–1263

    PubMed  CAS  Google Scholar 

  • Feary JR, Venn AJ, Mortimer K, Brown AP, Hooi D, Falcone FH, Pritchard DI, Britton JR (2010) Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy 40:299–306

    PubMed  CAS  Google Scholar 

  • Feldmann M, Maini RN (2010) Anti-TNF therapy, from rationale to standard of care: What lessons has it taught us? J Immunol 185:791–794

    PubMed  CAS  Google Scholar 

  • Fleming J, Isaak A, Lee J, Luzzio C, Carrithers M, Cook T, Field A, Boland J, Fabry Z (2011) Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler. doi:10.1177/1352458511398054

  • Friese MA, Montalban X, Willcox N, Bell JI, Martin R, Fugger L (2006) The value of animal models for drug development in multiple sclerosis. Brain 129:1940–1952

    PubMed  Google Scholar 

  • Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953–1971

    PubMed  Google Scholar 

  • Goodridge HS, Deehan MR, Harnett W, Harnett MM (2005a) Subversion of immunological signalling by a filarial nematode phosphorylcholine-containing secreted product. Cell Signal 17:11–16

    PubMed  CAS  Google Scholar 

  • Goodridge HS, Marshall FA, Else KJ, Houston KM, Egan C, Al-Riyami L, Liew FY, Harnett W, Harnett MM (2005b) Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol 174:284–293

    PubMed  CAS  Google Scholar 

  • Goodridge HS, Stepek G, Harnett W, Harnett MM (2005c) Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62. Immunology 115:296–304

    PubMed  CAS  Google Scholar 

  • Harada M, Kishimoto Y, Makino S (1990) Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 8:85–89

    PubMed  CAS  Google Scholar 

  • Harn DA, McDonald J, Atochina O, Da’dara AA (2009) Modulation of host immune responses by helminth glycans. Immunol Rev 230:247–257

    PubMed  CAS  Google Scholar 

  • Harnett W, Harnett MM (2010) Helminth-derived immunomodulators: Can understanding the worm produce the pill? Nat Rev Immunol 10:278–284

    PubMed  CAS  Google Scholar 

  • Harnett MM, Melendez AJ, Harnett W (2009) The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol 159:256–267

    PubMed  Google Scholar 

  • Harris J, Keane J (2010) How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 161:1–9

    PubMed  CAS  Google Scholar 

  • Haworth C, Brennan FM, Chantry D, Turner M, Maini RN, Feldmann M (1991) Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha. Eur J Immunol 21:2575–2579

    PubMed  CAS  Google Scholar 

  • Hegen M, Keith JC Jr, Collins M, Nickerson-Nutter CL (2008) Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 67:1505–1515

    PubMed  CAS  Google Scholar 

  • Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692–1698

    PubMed  CAS  Google Scholar 

  • Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA (2005) A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54:1763–1769

    PubMed  CAS  Google Scholar 

  • Hubner MP, Stocker JT, Mitre E (2009) Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 127:512–522

    PubMed  CAS  Google Scholar 

  • Hutchings P, O’Reilly L, Parish NM, Waldmann H, Cooke A (1992) The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice. Eur J Immunol 22:1913–1918

    PubMed  CAS  Google Scholar 

  • Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055

    PubMed  CAS  Google Scholar 

  • Imai S, Tezuka H, Fujita K (2001) A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun 286:1051–1058

    PubMed  CAS  Google Scholar 

  • Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498

    PubMed  CAS  Google Scholar 

  • Karumuthil-Melethil S, Perez N, Li R, Vasu C (2008) Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J Immunol 181:8323–8334

    PubMed  CAS  Google Scholar 

  • Keane J (2005) TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) 44:714–720

    CAS  Google Scholar 

  • Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098–1104

    PubMed  CAS  Google Scholar 

  • Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031

    PubMed  CAS  Google Scholar 

  • Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598–2608

    PubMed  CAS  Google Scholar 

  • Keymeulen B, Candon S, Fafi-Kremer S, Ziegler A, Leruez-Ville M, Mathieu C, Vandemeulebroucke E, Walter M, Crenier L, Thervet E, Legendre C, Pierard D, Hale G, Waldmann H, Bach JF, Seigneurin JM, Pipeleers D, Chatenoud L (2010) Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood 115:1145–1155

    PubMed  CAS  Google Scholar 

  • Kikutani H, Makino S (1992) The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285–322

    PubMed  CAS  Google Scholar 

  • Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P et al (1993) Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443–1453

    PubMed  CAS  Google Scholar 

  • Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711–715

    PubMed  CAS  Google Scholar 

  • Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS (2009) Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 33:239–246

    PubMed  CAS  Google Scholar 

  • Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811–822

    PubMed  CAS  Google Scholar 

  • Krishnamoorthy G, Wekerle H (2009) EAE: an immunologist’s magic eye. Eur J Immunol 39:2031–2035

    PubMed  CAS  Google Scholar 

  • La Flamme AC, Ruddenklau K, Backstrom BT (2003) Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 71:4996–5004

    PubMed  CAS  Google Scholar 

  • Lee IF, Qin H, Trudeau J, Dutz J, Tan R (2004) Regulation of autoimmune diabetes by complete Freund’s adjuvant is mediated by NK cells. J Immunol 172:937–942

    PubMed  CAS  Google Scholar 

  • Leger OJ, Yednock TA, Tanner L, Horner HC, Hines DK, Keen S, Saldanha J, Jones ST, Fritz LC, Bendig MM (1997) Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis. Hum Antibodies 8:3–16

    PubMed  CAS  Google Scholar 

  • Lehuen A, Diana J, Zaccone P, Cooke A (2010) Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 10:501–513

    PubMed  CAS  Google Scholar 

  • Levine S, Sowinski R (1973) Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol 110:139–143

    PubMed  CAS  Google Scholar 

  • Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594–1602

    PubMed  CAS  Google Scholar 

  • Lipton MM, Freund J (1952) Encephalomyelitis in the rat following intracutaneous injection of central nervous system tissue with adjuvant. Proc Soc Exp Biol Med 81:260–261

    PubMed  CAS  Google Scholar 

  • Lobb RR, Hemler ME (1994) The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 94:1722–1728

    PubMed  CAS  Google Scholar 

  • Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1–13

    PubMed  CAS  Google Scholar 

  • Marliss EB, Nakhooda AF, Poussier P, Sima AA (1982) The diabetic syndrome of the ‘BB’ Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia 22:225–232

    PubMed  CAS  Google Scholar 

  • Martins TC, Aguas AP (1999) A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes. Immunology 96:600–605

    PubMed  CAS  Google Scholar 

  • Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625

    PubMed  CAS  Google Scholar 

  • McInnes IB, Leung BP, Harnett M, Gracie JA, Liew FY, Harnett W (2003) A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 171:2127–2133

    PubMed  CAS  Google Scholar 

  • Melendez AJ, Harnett MM, Pushparaj PN, Wong WS, Tay HK, McSharry CP, Harnett W (2007) Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat Med 13:1375–1381

    PubMed  CAS  Google Scholar 

  • Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803

    PubMed  CAS  Google Scholar 

  • Nabozny GH, Kong YC (1992) Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta. J Immunol 149:1086–1092

    PubMed  CAS  Google Scholar 

  • Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B (2004) Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves’ hyperthyroidism. J Immunol 173:2167–2173

    PubMed  CAS  Google Scholar 

  • Ohsugi T, Kurosawa T (1994) Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. Lab Anim Sci 44:386–388

    PubMed  CAS  Google Scholar 

  • Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702

    PubMed  CAS  Google Scholar 

  • Osada Y, Shimizu S, Kumagai T, Yamada S, Kanazawa T (2009) Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol 39:457–464

    PubMed  CAS  Google Scholar 

  • Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033

    PubMed  Google Scholar 

  • Phillips JM, Parish NM, Bland C, Sawyer Y, De La Pena H, Cooke A (2009) Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations. Rev Diabet Stud 6:97–103

    PubMed  Google Scholar 

  • Pritchard DI, Todd I, Brown A, Bycroft BW, Chhabra SR, Williams P, Wood P (2005) Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-l-homoserine lactone. Acta Diabetol 42:119–122

    PubMed  CAS  Google Scholar 

  • Raine T, Zaccone P, Mastroeni P, Cooke A (2006) Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 177:2224–2233

    PubMed  CAS  Google Scholar 

  • Rasooly L, Burek CL, Rose NR (1996) Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 81:287–292

    PubMed  CAS  Google Scholar 

  • Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T (2008) Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 359:2849–2850

    PubMed  CAS  Google Scholar 

  • Ritchie AJ, Whittall C, Lazenby JJ, Chhabra SR, Pritchard DI, Cooley MA (2007) The immunomodulatory Pseudomonas aeruginosa signalling molecule N-(3-oxododecanoyl)-l-homoserine lactone enters mammalian cells in an unregulated fashion. Immunol Cell Biol 85:596–602

    PubMed  CAS  Google Scholar 

  • Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39–53

    PubMed  CAS  Google Scholar 

  • Roep BO (2007) Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci 1103:1–10

    PubMed  CAS  Google Scholar 

  • Rose NR, Twarog FJ, Crowle AJ (1971) Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol 106:698–704

    PubMed  CAS  Google Scholar 

  • Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107:12204–12209

    PubMed  CAS  Google Scholar 

  • Rubin SA, Yednock TA, Carbone KM (1998) In vivo treatment with anti-alpha4 integrin suppresses clinical and pathological evidence of Borna disease virus infection. J Neuroimmunol 84:158–163

    PubMed  CAS  Google Scholar 

  • Sadelain MW, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583–589

    PubMed  CAS  Google Scholar 

  • Sai P, Rivereau AS (1996) Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab 22:341–348

    PubMed  CAS  Google Scholar 

  • Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454–460

    PubMed  CAS  Google Scholar 

  • Saunders KA, Raine T, Cooke A, Lawrence CE (2007) Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 75:397–407

    PubMed  CAS  Google Scholar 

  • Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z (2003) Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 15:59–69

    PubMed  CAS  Google Scholar 

  • Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie AN, van Rooijen N, Fallon PG (2007) Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178:4557–4566

    PubMed  CAS  Google Scholar 

  • Sriram S, Steiner I (2005) Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 58:939–945

    PubMed  CAS  Google Scholar 

  • Steinman L (2005) Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nat Rev Drug Discov 4:510–518

    PubMed  CAS  Google Scholar 

  • Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60:12–21

    PubMed  CAS  Google Scholar 

  • Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260

    PubMed  CAS  Google Scholar 

  • Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV (2005a) Trichuris suis therapy in Crohn’s disease. Gut 54:87–90

    PubMed  CAS  Google Scholar 

  • Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005b) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825–832

    PubMed  Google Scholar 

  • Taneja V, David CS (2010) Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. Immunol Rev 233:62–78

    PubMed  CAS  Google Scholar 

  • Thomas PG, Carter MR, Atochina O, Da’Dara AA, Piskorska D, McGuire E, Harn DA (2003) Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol 171:5837–5841

    PubMed  CAS  Google Scholar 

  • Todd JA (2010) Etiology of type 1 diabetes. Immunity 32:457–467

    PubMed  CAS  Google Scholar 

  • Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599–604

    PubMed  CAS  Google Scholar 

  • Toyota T, Satoh J, Oya K, Shintani S, Okano T (1986) Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice. Diabetes 35:496–499

    PubMed  CAS  Google Scholar 

  • Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146:857–868

    PubMed  CAS  Google Scholar 

  • Van Liempt E, Imberty A, Bank CM, Van Vliet SJ, Van Kooyk Y, Geijtenbeek TB, Van Die I (2004) Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens. J Biol Chem 279:33161–33167

    PubMed  Google Scholar 

  • van Liempt E, van Vliet SJ, Engering A, Garcia Vallejo JJ, Bank CM, Sanchez-Hernandez M, van Kooyk Y, van Die I (2007) Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol Immunol 44:2605–2615

    PubMed  Google Scholar 

  • Velupillai P, Harn DA (1994) Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci USA 91:18–22

    PubMed  CAS  Google Scholar 

  • Vladutiu AO, Rose NR (1971) Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 174:1137–1139

    PubMed  CAS  Google Scholar 

  • Wallis RS (2007) Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma. J Investig Dermatol Symp Proc 12:16–21

    PubMed  CAS  Google Scholar 

  • Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183:1577–1586

    PubMed  CAS  Google Scholar 

  • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253–259

    PubMed  CAS  Google Scholar 

  • Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35–45

    PubMed  CAS  Google Scholar 

  • Williams RO, Feldmann M, Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89:9784–9788

    PubMed  CAS  Google Scholar 

  • Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:541–546

    PubMed  CAS  Google Scholar 

  • Xu D, Alegre ML, Varga SS, Rothermel AL, Collins AM, Pulito VL, Hanna LS, Dolan KP, Parren PW, Bluestone JA, Jolliffe LK, Zivin RA (2000) In vitro characterization of five humanized OKT3 effector function variant antibodies. Cell Immunol 200:16–26

    PubMed  CAS  Google Scholar 

  • Yang XD, Michie SA, Tisch R, Karin N, Steinman L, McDevitt HO (1994) A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 91:12604–12608

    PubMed  CAS  Google Scholar 

  • Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63–66

    PubMed  CAS  Google Scholar 

  • Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A (2003) Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33:1439–1449

    PubMed  CAS  Google Scholar 

  • Zaccone P, Raine T, Sidobre S, Kronenberg M, Mastroeni P, Cooke A (2004) Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol 34:3246–3256

    PubMed  CAS  Google Scholar 

  • Zaccone P, Burton O, Miller N, Jones FM, Dunne DW, Cooke A (2009) Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 39:1098–1107

    PubMed  CAS  Google Scholar 

  • Zaccone P, Burton OT, Gibbs S, Miller N, Jones FM, Dunne DW, Cooke A (2010) Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol 2010:795210

    PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to The Wellcome Trust and to Diabetes UK for supporting our research. Samuel W. Hall is funded by generous financial support from Corpus Christi College, Cambridge.

Author information

Authors and Affiliations

  1. Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK

    Samuel W. Hall & Anne Cooke

Authors
  1. Samuel W. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Cooke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samuel W. Hall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, S.W., Cooke, A. Autoimmunity and inflammation: murine models and translational studies. Mamm Genome 22, 377–389 (2011). https://doi.org/10.1007/s00335-011-9338-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00335-011-9338-2

Keywords

Search

Navigation